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Abstract: 
Glucose-stimulated insulin secretion (GSIS) from the pancreatic β-cell in response to elevated levels of 
glucose is controlled by a variety of signals including intracellular calcium and nucleotides such as 
cAMP, ATP and GTP. These cellular signals are responsible for activation of specific kinases that 
mediate phosphorylation of key exocytotic proteins that lead to GSIS. In the context of protein kinases, 
mixed-lineage kinases (MLKs) have been implicated in an assortment of cellular functions, including cell 
proliferation and apoptosis. However, very little is known on potential regulatory roles of MLKs in islet 
β-cell function, including GSIS. The goal of this study is to determine the roles of MLK3 in GSIS. Initial 
data indicated that MLK3 is expressed in clonal β-cells (INS-1 832/13) and human islets. INS-1 832/13 
cell exposure to stimulatory glucose (20mM) resulted in a time-dependent increase in phosphorylation of 
MLK3 at T277 and S281 with peak phosphorylation within 20 minutes. URMC-099, a known inhibitor of 
MLK3, markedly suppressed glucose-induced MLK3 phosphorylation under stimulatory glucose 
conditions. Moreover, URMC-099 significantly increased insulin secretion under basal (2.5mM) and 
stimulatory glucose exposure conditions, suggesting a suppressive role for MLK3 in insulin secretion. 
Together, these studies provide evidence that MLK3 is in fact expressed in clonal and primary β-cells and 
inhibition of glucose-induced phosphorylation of MLK3 results in potentiation of GSIS. Studies are 
underway to further confirm our pharmacological findings using molecular biological (siRNA-MLK3) 
approaches. 
 
 
